Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis

Advances in Therapy

Volumn 29, Issue 5, 2012, Pages 416-426

  Belfort Jr , Rubens ^a   Gabriel, Luis ^a   Bispo, Paulo José Martins ^a   Muccioli, Cristina ^a   Serapicos, Patricia Cabral Zacharias ^a   Clark, Linda ^b   Bell, Belinda ^b   Bartell, John ^b   Stroman, David W ^c   Höfling Lima, Luisa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b ALCON RESEARCH LTD   (United States)

^c NONE

Author keywords

Blepharitis; Conjunctivitis; Dexamethasone; Keratitis; Moxifloxacin

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE PLUS MOXIFLOXACIN; EYE DROPS; MOXIFLOXACIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARM FORMICATION; ARTICLE; BACTERIAL BLEPHARITIS; BACTERIAL EYE INFECTION; BACTERIAL KERATITIS; BLEPHARITIS; BURNING SENSATION; CONJUNCTIVA; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DESQUAMATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY COUGH; DRY EYE; EYELID; EYELID ERYTHEMA; FEMALE; FORMICATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART PALPITATION; HORDEOLUM; HUMAN; HYPERGLYCEMIA; INSOMNIA; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOM;

ADMINISTRATION, OPHTHALMIC; ADULT; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BLEPHARITIS; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EYE INFECTIONS, BACTERIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; QUINOLINES;

EID: 84863722588     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-012-0018-8     Document Type: Article

References (7)

1. Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003;20:246-52. (Pubitemid 38101667)
2. Miller D. Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clin Ophth. 2008;2:77-91.
3. International Council of Ophthalmology International Clinical Guidelines. Blepharitis. Available at: www.icoph.org/resources/76/ICO-International- Clinical-Guideline-Blepharitis-Initial-and-follow-up-evaluation-.html. Accessed April 2 2012.
4. American Academy of Ophthalmology. Blepharitis Preferred Practice Pattern. Available at: http://one.aao.org/CE/PracticeGuidelines/PPP-Content. aspx?cid=500cd9ca-173c-4c31-b6ea-a258e3549474. Accessed April 2 2012.
5. Campos M, Avila M, Wallau A, Muccioli C, Hofling-Lima AL, Belfort R. Efficacy and tolerability of a fixed-dose moxifloxacin-dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial. Clin Ophth. 2008;2:331-8.
6. Freitas LL, Soriano E, Muccioli C, Hofling-Lima AL, Belfort R, Jr. Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial. Curr Med Res Opin. 2007;23:3123-30.
7. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533-40.